NCT07021092

Brief Summary

The study aims to increase the reach of the person-centred interpersonal practices by developing and accessing a tailored, scalable, and sustainable approach that meets the distinctive needs of populations identified as most disproportionately affected by viremia in Zambia. The study population include pregnant and breastfeeding women, children, adolescents and adult that are more than thirty -30 days late for their next hospital appointments.The study will be implemented over a period of 36 months in 24 facilities in Lusaka and Central province, Zambia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Apr 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Apr 2025Jun 2027

First Submitted

Initial submission to the registry

March 25, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

1.9 years

First QC Date

March 25, 2025

Last Update Submit

June 12, 2025

Conditions

Keywords

Uncontrolled ViremiaPerson Centred CareUnmonitored Viral Load

Outcome Measures

Primary Outcomes (1)

  • Updated Estimates of Viremia and Care Status

    The study will use a sampling based approach for outcome ascertainment as used in the Better Information for Health in Zambia(BetterInfo) study https://www.cidrz.org/wp-content/toolkits/betterinfo/, but adapt procedures so they are focused on assessments of viremia (rather than mortality as in the initial BetterInfo study) (21). This approach leverages data collected during routine care and augments it with targeted data collection in a smaller sample of clients with incomplete data (i.e., missing VL measurements) to provide robust and epidemiologically rigorous estimates for the full clinic population.

    2 years

Study Arms (1)

Tracing to Ascertain Outcome

OTHER
Other: Interventions will be developed in aim 2 of the study.

Interventions

Person-centred package that connects patients to service delivery, builds rapports and improves engagement in care leading to sustained viral load suppressions

Also known as: Possible interventions to be developed will include 1) community- based outreach and in-person tracing to identify and establish contact with viremic patients and establish barriers to care, Improved counselling using PCC and being non-judgemental as a way of establishing rapport and relationship with individuals using PCC approach tailored to barriers, Facility based Viral load champions, couple counselling and access to DSD models as a way of providing structural interventions to bring individuals back to care, keep them in care and maintain VL sup
Tracing to Ascertain Outcome

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients that are lost to follow up (\[LTFU\] from HIV care i.e. confirmed \>30 days late for a scheduled appointment) at the time of sampling. (i.e. not people who were previously LTFU but then returned and have a documented VL.)
  • Individuals returning to care after being out of care and not taking ART with no VL measure (i.e., unmeasured viremia)
  • Patients that are 6 months late for a scheduled Viral Load (VL) according to Ministry of Health guidelines at the time of sampling (regardless of care status)
  • Patients that have a last documented VL that is elevated, \> 1000 copies/ml at time of sampling in current clinic population (CCP) (regardless of care status)
  • Participant that are willing to provide written informed consent in English, or any of the local languages that include Nyanja or Bemba.

You may not qualify if:

  • Patients that are unable to provide consent or unwilling to participate in the study
  • Participant who is NOT living with HIV/AIDS;
  • Participant is too sick i.e., failing to talk, general discomfort and emergency cases);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ministry of Health

Lusaka, Lusaka Province, 10101, Zambia

NOT YET RECRUITING

Railway GRZ Urban Health Centre, Kafue District Health Hospital, Nangongwe OPD Urban Health Centre, Chawama 1st level hospital, Chipate 1st level hospital, Matero Reference Health Centre, Mtendere Health Centre, Lwiimba Rural Health Centre

Lusaka, Lusaka Province, 10101, Zambia

RECRUITING

Related Publications (1)

  • Ehrenkranz P, Rosen S, Boulle A, Eaton JW, Ford N, Fox MP, Grimsrud A, Rice BD, Sikazwe I, Holmes CB. The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals. PLoS Med. 2021 May 24;18(5):e1003651. doi: 10.1371/journal.pmed.1003651. eCollection 2021 May.

    PMID: 34029346BACKGROUND

Related Links

MeSH Terms

Interventions

Association

Intervention Hierarchy (Ancestors)

Psychotherapeutic ProcessesPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Dr Aaloke Mody

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Kombatende Sikombe

    Centre for Infectious Disease Research in Zambia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2025

First Posted

June 13, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations